These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31983511)

  • 81. GPR142 prompts glucagon-like Peptide-1 release from islets to improve β cell function.
    Lin HV; Wang J; Wang J; Li W; Wang X; Alston JT; Thomas MK; Briere DA; Syed SK; Efanov AM
    Mol Metab; 2018 May; 11():205-211. PubMed ID: 29506910
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The role of GIP in α-cells and glucagon secretion.
    El K; Campbell JE
    Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pancreatic network control of glucagon secretion and counterregulation.
    Farhy LS; McCall AL
    Methods Enzymol; 2009; 467():547-581. PubMed ID: 19897107
    [TBL] [Abstract][Full Text] [Related]  

  • 84. cAMP signalling in insulin and glucagon secretion.
    Tengholm A; Gylfe E
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():42-53. PubMed ID: 28466587
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases.
    Hædersdal S; Andersen A; Knop FK; Vilsbøll T
    Nat Rev Endocrinol; 2023 Jun; 19(6):321-335. PubMed ID: 36932176
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans.
    Jonsson A; Ladenvall C; Ahluwalia TS; Kravic J; Krus U; Taneera J; Isomaa B; Tuomi T; Renström E; Groop L; Lyssenko V
    Diabetes; 2013 Aug; 62(8):2978-83. PubMed ID: 23557703
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Fluorescein-based sensors to purify human α-cells for functional and transcriptomic analyses.
    Kahraman S; Shibue K; De Jesus DF; Kim H; Hu J; Manna D; Wagner B; Choudhary A; Kulkarni RN
    Elife; 2023 Sep; 12():. PubMed ID: 37732504
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Integrated human pseudoislet system and microfluidic platform demonstrate differences in GPCR signaling in islet cells.
    Walker JT; Haliyur R; Nelson HA; Ishahak M; Poffenberger G; Aramandla R; Reihsmann C; Luchsinger JR; Saunders DC; Wang P; Garcia-Ocaña A; Bottino R; Agarwal A; Powers AC; Brissova M
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32352931
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evidence for a Neogenic Niche at the Periphery of Pancreatic Islets.
    Huising MO; Lee S; van der Meulen T
    Bioessays; 2018 Nov; 40(11):e1800119. PubMed ID: 30264410
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Glucose controls glucagon secretion by directly modulating cAMP in alpha cells.
    Yu Q; Shuai H; Ahooghalandari P; Gylfe E; Tengholm A
    Diabetologia; 2019 Jul; 62(7):1212-1224. PubMed ID: 30953108
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Paracrinology of islets and the paracrinopathy of diabetes.
    Unger RH; Orci L
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16009-12. PubMed ID: 20798346
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
    Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
    Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The physiology of glucagon.
    Taborsky GJ
    J Diabetes Sci Technol; 2010 Nov; 4(6):1338-44. PubMed ID: 21129328
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Brief overview: glucagon history and physiology.
    Robertson RP
    J Endocrinol; 2023 Aug; 258(2):. PubMed ID: 37227172
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets.
    Le Marchand SJ; Piston DW
    J Biol Chem; 2010 May; 285(19):14389-98. PubMed ID: 20231269
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Impact of islet alpha cell loss on insulin secretion].
    Li G; Ye L; Li J; Yang W; Lou J
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1427-31. PubMed ID: 12509929
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reduced Expression of the Co-regulator TLE1 in Type 2 Diabetes Is Associated with Increased Islet α-Cell Number.
    Armour SL; Anderson SJ; Richardson SJ; Ding Y; Carey C; Lyon J; Maheshwari RR; Al-Jahdami N; Krasnogor N; Morgan NG; MacDonald P; Shaw JAM; White MG
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32065829
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [The principles of the treatment of pancreatic diabetes].
    Iván G
    Orv Hetil; 2009 Feb; 150(6):273-6. PubMed ID: 19179260
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
    Farhy LS; McCall AL
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pancreatic β Cells Inhibit Glucagon Secretion from α Cells: An In Vitro Demonstration of α-β Cell Interaction.
    Gu W; Anker CCB; Christiansen CB; Moede T; Berggren PO; Hermansen K; Gregersen S; Jeppesen PB
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.